Background: Voriconazole Resistance (VRC-R) in
Aspergillus flavus isolates impacts the management of aspergillosis, since azoles are the first choice for prophylaxis and therapy. However, to the best of our knowledge, the mechanisms underlying voriconazole resistance are poorly understood. Objectives: The present study was designed to evaluate mRNA expression levels of
cyp51A and
mdr1 genes in voriconazole resistant
A. flavus by a Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) technique. Materials and Methods: Five
A. flavus isolates with resistance to VRC were examined by a RT-PCR approach. Results: Four out of five isolates revealed
cyp51A and
mdr1 mRNA overexpression. Interestingly, the isolate, which was negative for
cyp51A and
mdr1 mRNA expression showed a high voriconazole Minimum Inhibitory Concentration (MIC). Furthermore, a computational-based analysis predicted that voriconazole resistance could be mediated through cooperation with a network protein interaction. Conclusions: Our experimental and
in silico findings may provide new insight in the complex molecular pathways of drug resistance and also could assist design an efficient therapeutic strategy for aspergillosis treatment. Keywords: Drug Resistance; Minimum Inhibitory Concentration;
cyp51A; mdr1